Angiotensin II type 1 receptor blocker-induced immune thrombocytopenia: a case report

INTRODUCTION: The development of thrombocytopenia after a dose increase in losartan and subsequently after switching the patient to valsartan is reported. CASE PRESENTATION: A 61-year-old Caucasian man presented with epistaxis and gingival bleeding of three weeks duration. Laboratory evaluation reve...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Dhiren K, Bilkha, Nikhil, Schnee, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751637/
https://www.ncbi.nlm.nih.gov/pubmed/23856430
http://dx.doi.org/10.1186/1752-1947-7-183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751637/
https://www.ncbi.nlm.nih.gov/pubmed/23856430
http://dx.doi.org/10.1186/1752-1947-7-183

Ejemplares similares